Paper

Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.

Published Feb 1, 2009 · Takahiro Araki, M. Emoto, T. Konishi

Metabolism: clinical and experimental

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Study Snapshot

Glimepiride treatment improves plasma adiponectin levels and directly contributes to improving HDL-c levels in type 2 diabetes mellitus patients with low adiponectin levels.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.

References

Citations